Drug · DIN 02236951
SEROQUEL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 28, 2025; first marketed December 10, 1997.
- Drug Identification Number (DIN)
- 02236951
- Company (DIN owner)
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Quetiapine N05AH04
- Class
- Human
- Record last updated
- July 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| QUETIAPINE (QUETIAPINE FUMARATE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 18, 2025: NOC 35042New Drug Submission (NDS) · Administrative: Change in product ownership
- February 8, 2000: NOC 1430New Drug Submission (NDS)
- December 2, 1997: NOC 4039New Drug Submission (NDS)
Other DINs named SEROQUEL
- DIN 02236952 · Marketed
- DIN 02236953 · Marketed
- DIN 02244107 · Marketed
- DIN 02240862 · Cancelled Post Market